Europe Polymerase Chain Reaction Technologies Market Size to register a growth of 6.5% CAGR

13-02-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Europe Polymerase Chain Reaction Technologies Market, published by KBV research, the Europe Polymerase Chain Reaction Technologies Market would witness market growth of 6.5% CAGR during the forecast period (2018 – 2024).

The Germany market would dominate the Europe Polymerase Chain Reaction Technologies in Biotech & Pharma Companies Market by by 2024, growing at a CAGR of 4.5 % during the forecast period. The UK market is expected to witness a CAGR of 4.8% during (2018 - 2024). Additionally, The France market is expected to witness a CAGR of 7.2% during (2018 - 2024).

The Real-Time PCR market dominated the Europe Polymerase Chain Reaction Technologies Market by Technology in 2017. The Digital PCR market is expected to witness a CAGR of 8.8% during (2018 - 2024).

The Forensics market dominated the France Polymerase Chain Reaction Technologies Market by Application in 2017, and would achieve a market value of $186.1 million by 2024. The Research market is expected to witness a CAGR of 8.4% during (2018 - 2024).

Full Report:https://www.kbvresearch.com/europe-polymerase-chain-reaction-technologies-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.